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ABSTRACT: An efficient sequential intramolecular cyclization of amino alcohol carbamates followed by Cu-catalyzed 
cross–coupling with aryl iodides under mild conditions has been developed. The reaction occurred in good yields and 
tolerated aryl iodides containing functionalities such as nitriles, ketones, ethers and halogens. Heteroaryl iodides and 
substituted amino alcohol carbamates were also well tolerated.  
Antimicrobial resistance is a growing area of concern in 
modern medicine. Newly emerging resistance mechanisms 
towards antibiotics is gradually reducing the latest genera-
tion of antibiotics’ effectiveness towards the treatment of 
numerous infectious diseases. N-Aryl oxazolidinones have 
gained significant interest in the recent decade since the 
discovery of a new antibiotic class effective against vanco-
mycin-resistant enterococci (VRE) and methicillin-resistant 
Staphylococcus aureus (MRSA).1 N-Aryl oxazolidinones 
have also shown pharmacological activity as treatments for 
depression and psychosis (Figure 1).2 A number of synthet-
ic methods have been established towards the synthesis of 
these compounds,3 however few examples were found 
where oxazolidinone formation and functionalization were 
achieved in a one-pot process.4  
The development of both palladium and copper catalyzed 
carbon-heteroatom bond-formation has resulted in elegant 
examples of catalytic heterocycle synthesis.6 It has been 
extensively shown that oxazolidinones can be efficiently 
coupled with the corresponding aryl halide under metal 
catalyzed cross-coupling conditions. Copper-catalyzed 
Ullmann-Goldberg couplings of aryl iodides and aryl bro-
mides with 2-oxazolidinone is well known in the literature,7 
however as is common with a copper cross-coupling reac-
tion, elevated temperatures and high boiling solvents are 
generally required. The effectiveness of palladium-catalyzed 
N-arylation of oxazolidinone with aryl halides and heteroar-
omatic tosylates has been demonstrated,8 and work by 
Ghosh has developed effective systems for the reaction of 
aryl chlorides.9 However the use of palladium also requires 
the use of specialized and often expensive phosphine lig-
ands. 
 
Figure 1. Bioactive Compounds Containing an N-Aryl 
Oxazolidinone Structural Core. Linezolid and Posizolid 
are applied for the treatment of bacterial infection and 
Toloxatone and Befloxatone as treatments for depres-
sion as a reversible inhibitor of MAO-A.5 
 
Herein we wish to disclose a novel copper-catalyzed one-
pot methodology towards the synthesis of N-aryl oxazoli-
dinones derived from amino alcohols and aryl iodides. Key 
advantages of this developed methodology draw from the 
high commercial availability of starting material precursors, 
the potential to access a diverse and abundant chiral pool 
as well as the application of an inexpensive catalyst/ligand 
system in a common, low boiling organic solvent. 
To begin our study, we chose BOC-protected ethanolamine 
and iodobenzene as model substrates to identify suitable 
reaction conditions. As is common with copper-catalyzed 
systems, activity is largely dependent on the selection of a 
suitable ligand.10 
 
  
Table 1. Optimization of Reaction Conditionsa  
 
entry Temp. 
(oC) 
carbamate ligand solventb base base (equiv) Ar-I (equiv) yield 
(%)c 
1 120 tBu - PrCN Cs2CO3 1.5 1 25 
2 120 tBu L1 PrCN Cs2CO3 1.5 1 30d 
3 120 tBu L2 PrCN Cs2CO3 1.5 1 57 
4 120 tBu L3 PrCN Cs2CO3 1.5 1 62 
5 100 tBu L3 PrCN Cs2CO3 1.5 1 70 
6 100 Bn L3 PrCN Cs2CO3 1.5 1 72 
7 100 Et L3 PrCN Cs2CO3 1.5 1 78 
8 100 Me L3 PrCN Cs2CO3 1.5 1 78 
9 80 Et L3 PrCN Cs2CO3 1.5 1 30 
10 80 Et L3 THF Cs2CO3 1.5 1 78 
11 80 Et L3 toluene Cs2CO3 1.5 1 30 
12 80 Et L3 Me-THF Cs2CO3 1.5 1 12 
13 80 Et L3 MeCN Cs2CO3 1.5 1 46 
14 80 Et L3 MeCN Cs2CO3 1.5 1 76 
15 80 Et L3 MeCN Cs2CO3 1 1 40 
16 80 Et L3 MeCN Cs2CO3 2 1 86 
17 80 Et L3 MeCN Cs2CO3 3 1 72 
18 80 Et L3 MeCN Cs2CO3 2 1.5 88 
19 80 Et L3 MeCN Cs2CO3 2 2 92 
20 80 Et L3 MeCN Cs2CO3 2 3 96 
21 80 Et L3 MeCN Cs2CO3 2 3 NR 
a Unless otherwise stated, the reaction was conducted with 1 (1 mmol), CuI (0.1 mmol), ligand (0.2 mmol, solvent (2 mL) un-
der air, 20 h. L1 = 3,4,7,8-tetramethyl-1,10-phenanthroline, L2 = 2,2,6,6-tetramethylheptane-3,5-dione, L3 = 2-
isobutyrylcyclohexanone b PrCN = butyronitrile, THF = tetrahydrofuran, Me-THF = 2-methyltetrahydrofuran, MeCN = acetoni-
trile. c Isolated yield. d Observation of competitive O-arylation (7%). eCuI (0.05 mmol). 
A number of ligands commonly associated with copper-
catalyzed C-N cross couplings were used in the presence of 
10 mol % of CuI as catalyst, 1.5 equiv of Cs2CO3 as base in 
toluene. The results showed that phenanthroline-based 
ligands gave poorer activity over ligand free conditions. 
When alkyl diketone ligands were used, the desired cross-
coupled N-aryl oxazolidinone was obtained in an improved 
yield.11 
Varying the carbamate group was also shown to have a 
profound effect, ethylcarbamate coupled ethanolamine be-
ing found to be the best choice. We subsequently used tet-
ramethylheptanedione as the ligand and ethyl carbamate 
ethanolamine as the oxazolidinone precursor to further test 
the solvent. A screen of solvents showed the preference for 
polar aprotic solvents, THF and acetonitrile proving to be 
the most effective (Table 1). Despite an improved yield of 
desired product being achieved in THF, additional byprod-
ucts of O-arylated starting material was observed. Work 
published by Buchwald has demonstrated that copper-
catalyzed N vs O-arylations can be greatly affected by the 
choice of solvent. Consistent with Buchwald’s work, THF 
was conducive towards more favourable O-arylation, and as 
such acetonitrile was used in further optimizations to afford 
a selective reaction.12 
Variation of the base showed that alternative inorganic and 
organic bases were totally ineffective for this transformation. 
Variation of equivalences of base and aryl iodide showed 
improvement in the presence of excess base and aryl io-
dide. The reaction was also shown to be relatively inde-
pendent of reaction concentration. Under the reaction condi-
tions the reduction in catalytic loading of copper iodide to 5 
% was shown to have a significant reduction in desired 
product formation. Reactions performed in the absence of 
catalyst yielded only the uncoupled oxazolidinone. 
 In order to demonstrate the generality of this one-pot meth-
odology the substrate scope was investigated under the 
optimized reaction conditions (Scheme 1). We first surveyed 
the compatibility of substituted aryl iodides. Aryl iodides with 
electron withdrawing substituents were coupled under the 
reaction conditions in good to excellent yields with high tol-
erance of a number of functional handles (CN, CO2Me, 
C(O)CH3, F, Br). In the case of the methyl ester substituent, 
transesterification to the ethyl ester was observed due to 
 the formation of the ethoxide anion generated upon cyclisa-
tion. Decreased yields were also observed due to competi-
tive transesterification with the ethanolamine-derived start-
ing material. However, a significant yield of the desired cou-
pled product was obtained. Electron-withdrawing substitu-
ents showed slightly reduced yields than expected as the 
strongly withdrawing nature increased the susceptibility of 
the N-aryl oxazolidinone towards ring-opening, to yield the 
corresponding N-aryl ethanolamine. In the case of 4-
nitrobenzene no desired product was obtained, and the 
major products were a mixture of N-, NN- and NNO- ary-
lated ethanolamine. Substituents were well tolerated at the 
meta and para positions on the aromatic ring, however or-
tho substituents gave little to no cross-coupled product. 
 
Scheme 1. Copper Catalyzed One-Pot Synthesis of N-
aryl Oxazolidinonesa 
 
 
 
a Reaction conditions: 1 (1 mmol), Ar-I (2 mmol), CuI (10 
mol %), ligand (20 mol %), Cs2CO3 (2 mmol), MeCN (4 mL) 
under air for 20 h. Isolated yields after silica gel chromatog-
raphy. b Performed at 100 oC. 
 
A number of hetero aryl iodides were investigated and 
showed excellent tolerance for nitrogen and sulfur contain-
ing aromatics. The addition of electron-donating substitu-
ents on the ring however significantly effected the extent of 
cross coupled product. A plot of the 1H NMR calculated 
conversions of crude reaction mixtures against the calculat-
ed Hammett constant (σ) showed a reduction in conversion 
to desired N-arylated oxazolidinone with decreasing Ham-
mett constant.13 This limitation is observed by a dramatic 
decline in conversion with even mildly electron donating 
substituents. To overcome these limitations elevated tem-
peratures were used. Increasing the temperature of the 
reaction to 100 oC afforded the desired N-aryl oxazoli-
dinones with electron rich aromatics in excellent yields. 
In addition, structurally diverse N-aryl oxazolidinones were 
prepared in good to excellent yields. Corresponding substi-
tuted oxazolidinones were prepared from amino alcohol 
derivatives and treated under the optimized reaction condi-
tions (Scheme 2). 5-substituted oxazolidinones proceeded 
well, tolerating significant steric bulk and silyl protected al-
cohols. 4-Substituted oxazolidinones required elevated 
temperatures in order to achieve satisfactory yields.14 
 
Scheme 2. Copper Catalyzed One-Pot Synthesis of 
amino acid derived N-aryl Oxazolidinonesa 
 
 
 
a Reaction conditions: 3a-l (1 mmol), Ar-I (2 mmol), CuI (10 
mol %), ligand (20 mol %), Cs2CO3 (2 mmol), MeCN (4 mL) 
under air for 20 h. Isolated yields after silica gel chromatog-
raphy. b Performed at 100 oC. 
 
The optimized reaction conditions were employed in a syn-
thesis of Toloxatone, a reversible inhibitor of MAO-A, that is 
used in the treatment of depression (Scheme 3). The de-
sired silyl ether intermediate was formed in excellent con-
version. A subsequent in situ mild deprotection was per-
formed to afford the corresponding unprotected product in 
excellent yield. 
 
 
 
Scheme 3. Synthesis of Antidepressant Toloxatonea 
 
  
a Reaction conditions: 3c (1 mmol), Ar-I (2 mmol). Isolated 
yields after silica gel chromatography.  
 
In conclusion, we have developed an efficient and mild CuI-
catalyzed one-pot cyclization and arylation for the synthesis 
of N-aryl oxazolidinones. The reaction is applicable to a 
wide range of substrates with various substituted aryl io-
dides and amino alcohol derivatives in good-to-excellent 
yields. The ease of synthesis of the amino alcohol precur-
sors, the performance under air using mild conditions, and 
the utilization of a cheap and abundant catalyst-ligand sys-
tem for this two-step, one-pot synthesis makes this process 
an attractive methodology for the preparation of important 
molecules. 
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